Khishov A.S., Burlakova G.I.
Summary. Aquaculture production is a promising direction for the development of food production. Like traditional types of animal husbandry, it needs effective medicines for veterinary use, which would ensure not only the well-being of farmed aquatic organisms, but also increase the safety of the fish products and non-fish objects of fishing. The development of measures to control epizootic processes in aquatic organisms is impossible without the creation of new immunological preparations. The development and use of immunobiological drugs will reduce the use of antimicrobial agents. The corresponding set of pharmaceutical drugs was transferred from the traditional veterinary medicine, but due to the peculiarities of the biology of aquatic animals, their immunity and the characteristics of specific pathogens, this could not be done with biological products. The short development time in the aquaculture industry poses current challenges in the form of a lack of basic and applied research for relatively poorly understood groups of new pathogens. The immunological processes associated with the development and intensity of the immune response in aquatic organisms require a detailed study. For domestic aquaculture producers, the analysis and dissemination of the experience accumulated by mankind and the application of advanced developments in this area are even more relevant, since Russia is just beginning its path of intensifying aquaculture production. At the same time, it is clear that the prohibition of the use and monitoring of antimicrobial agents in food products and feed requires a change in the approach to the problem and will lead to the creation of new immunobiological drugs. The market for immunobiological preparations for aquaculture is the most promising for development. In the article, the authors provide data on the development and registration of vaccines for aquaculture in Europe, North and South America.
Keywords: aquaculture, aquatic organisms, immunobiological preparations, vaccination, DNA vaccine, Atlantic salmon, infectious necrosis of hematopoietic tissue, Vibrio spp., Yersinia ruckeri, salmon yerseniosis, Aeromonas salmonicida.
1-8. Vide supra.
Khishov Andrey S., Chief Specialist of the Department for Control of genetically modified organisms of the All-Russian State Center for the Quality and Standardization of Medicines for Animals and Feed; 5, Zvenigorodskoe hgw., Moscow, 123022; phone: 8-905-5312277; e-mail: firstname.lastname@example.org.
Responsible for correspondence with the editorial board: Burlakova Galina I., Scientific Researcher of the Laboratory for Quality and Standardization of Bacterial Medicines of the All-Russian State Center for Quality and Standardization of Medicines for Animals and Feed; 5, Zvenigorodskoe hgw., Moscow, 123022; phone: 8-925-1080306; e-mail: email@example.com.